C
Cytek Biosciences, Inc. (CTKB)
NMS – Real vaqt narxi. Valyuta: USD
4.48
+0.01 (0.22%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.74
+0.26 (5.81%)
Bozordan keyin: Jun 26, 2026, 7:53 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
4.48
+0.01 (0.22%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.74
+0.26 (5.81%)
Bozordan keyin: Jun 26, 2026, 7:53 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $65.7M umumiy qarzdan $36.3M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $379.3M jami joriy majburiyatlardan $80.9M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.1) tarmoq o'rtachasidan (1.1) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-70.5x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$4.9M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 4.69 | 3.40 | 10 | |
| Tezkor likvidlik nisbati | 4.07 | 2.52 | 10 | |
| Qarz/Kapital nisbati | 0.11 | 1.11 | 9.0 | |
| Qarz/Aktivlar nisbati | 0.08 | 1.58 | 9.0 | |
| Foiz to‘lov qoplami | -70.47 | 4.33 | 1.0 | |
| O‘rtacha ball | 7.8 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 164M | 193M | 200M | 201M | 204M |
| Yalpi foyda | 102M | 109M | 111M | 104M | 106M |
| Operatsion daromad | -1M | -26M | -23M | -40M | -44M |
| Sof foyda | 3M | -12M | -6M | -67M | -74M |
| EBITDA | 4M | -17M | -13M | -28M | -32M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 6.6 | -112.5 | 3.0 |
| Keyingi chorak | 5.49 | -1527.55 | 3.0 |
| Joriy yil | 3.64 | 32.69 | 7.0 |
| Keyingi yil | 6.63 | 23.81 | 7.5 |
| O‘rtacha ball | 5.1 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -28.97 | 57.2 | 55.88 | -176.74 | 5.5 |
| Yil/Yil | 6.46 | -65.45 | -66.66 | -403.48 | 2.0 |
| 3 yil o‘rtacha | 7.35 | -508.8 | 28.54 | 1105.07 | 6.5 |
| 5 yil o‘rtacha | 17.61 | -125.47 | 1.96 | -1029.11 | 3.5 |
| O‘rtacha ball | 4.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |